Victory Capital Management Inc Celcuity Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$5.35 - $10.11 $449,881 - $850,149	-84,090 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$7.93 - $13.33 $50,989 - $85,711	6,430 Added 8.28%	84,090 $786,000
Q4 2021 Feb 07, 2022	SELL	$11.96 - $19.35 $44,132 - $71,401	-3,690 Reduced 4.54%	77,660 $1.02 Million
Q3 2021 Nov 02, 2021	SELL	$17.35 - $24.87 $9,195 - $13,181	-530 Reduced 0.65%	81,350 $1.46 Million
Q2 2021 Aug 03, 2021	BUY	$14.25 - $30.93 $1.17 Million - $2.53 Million	81,880 New	81,880 $1.97 Million
Q2 2020 Aug 07, 2020	SELL	$4.42 - $11.04 $3,690 - $9,218	-835 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$5.79 - $11.78 $110 - $223	-19 Reduced 2.22%	835 $5,000
Q4 2019 Feb 04, 2020	SELL	$9.47 - $16.71 $94 - $167	-10 Reduced 1.16%	854 $9,000
Q3 2019 Nov 12, 2019	BUY	$15.74 - $23.65 $13,599 - $20,433	864 New	864 $15,000

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $190M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.